Literature DB >> 17055079

Peroxisome biogenesis disorders.

Steven J Steinberg1, Gabriele Dodt, Gerald V Raymond, Nancy E Braverman, Ann B Moser, Hugo W Moser.   

Abstract

Defects in PEX genes impair peroxisome assembly and multiple metabolic pathways confined to this organelle, thus providing the biochemical and molecular bases of the peroxisome biogenesis disorders (PBD). PBD are divided into two types--Zellweger syndrome spectrum (ZSS) and rhizomelic chondrodysplasia punctata (RCDP). Biochemical studies performed in blood and urine are used to screen for the PBD. DNA testing is possible for all of the disorders, but is more challenging for the ZSS since 12 PEX genes are known to be associated with this spectrum of PBD. In contrast, PBD-RCDP is associated with defects in the PEX7 gene alone. Studies of the cellular and molecular defects in PBD patients have contributed significantly to our understanding of the role of each PEX gene in peroxisome assembly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055079     DOI: 10.1016/j.bbamcr.2006.09.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  176 in total

1.  Genome Wide Analysis of WD40 Proteins in Saccharomyces cerevisiae and Their Orthologs in Candida albicans.

Authors:  Buddhi Prakash Jain
Journal:  Protein J       Date:  2019-02       Impact factor: 2.371

Review 2.  The peroxisome: an update on mysteries.

Authors:  Markus Islinger; Sandra Grille; H Dariush Fahimi; Michael Schrader
Journal:  Histochem Cell Biol       Date:  2012-03-14       Impact factor: 4.304

3.  Peroxisomes, oxidative stress, and inflammation.

Authors:  Stanley R Terlecky; Laura J Terlecky; Courtney R Giordano
Journal:  World J Biol Chem       Date:  2012-05-26

4.  Insights into peroxisome function from the structure of PEX3 in complex with a soluble fragment of PEX19.

Authors:  Friederike Schmidt; Nora Treiber; Georg Zocher; Sasa Bjelic; Michel O Steinmetz; Hubert Kalbacher; Thilo Stehle; Gabriele Dodt
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

5.  A vesicle carrier that mediates peroxisome protein traffic from the endoplasmic reticulum.

Authors:  Sheung Kwan Lam; Naofumi Yoda; Randy Schekman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 6.  Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.

Authors:  Nancy E Braverman; Gerald V Raymond; William B Rizzo; Ann B Moser; Mark E Wilkinson; Edwin M Stone; Steven J Steinberg; Michael F Wangler; Eric T Rush; Joseph G Hacia; Mousumi Bose
Journal:  Mol Genet Metab       Date:  2015-12-23       Impact factor: 4.797

7.  Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.

Authors:  Mitchel A Kling; Dayan B Goodenowe; Vijitha Senanayake; Siamak MahmoudianDehkordi; Matthias Arnold; Tyler J Massaro; Rebecca Baillie; Xianlin Han; Yuk-Yee Leung; Andrew J Saykin; Kwangsik Nho; Alexandra Kueider-Paisley; Jessica D Tenenbaum; Li-San Wang; Leslie M Shaw; John Q Trojanowski; Rima F Kaddurah-Daouk
Journal:  Alzheimers Dement       Date:  2020-07-27       Impact factor: 21.566

8.  PPARα activation induces N(ε)-Lys-acetylation of rat liver peroxisomal multifunctional enzyme type 1.

Authors:  Miguel A Contreras; Oscar Alzate; Avtar K Singh; Inderjit Singh
Journal:  Lipids       Date:  2013-10-05       Impact factor: 1.880

9.  Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood.

Authors:  Chihiro Ohba; Hitoshi Osaka; Mizue Iai; Sumimasa Yamashita; Yume Suzuki; Noriko Aida; Nobuyuki Shimozawa; Ayumi Takamura; Hiroshi Doi; Atsuko Tomita-Katsumoto; Kiyomi Nishiyama; Yoshinori Tsurusaki; Mitsuko Nakashima; Noriko Miyake; Yoshikatsu Eto; Fumiaki Tanaka; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Neurogenetics       Date:  2013-10-04       Impact factor: 2.660

10.  Rational diagnostic strategy for Zellweger syndrome spectrum patients.

Authors:  Cindy Krause; Hendrik Rosewich; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2009-01-14       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.